Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology. Global|March 5, 2026
Implementation of early peanut introduction among providers in a southern US stateCallie Margiotta, Emily Seminara, Robert D Pesek, et al.The Journal of Allergy and Clinical Immunology. Global|February 26, 2025
Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysisAdam S Price, Akilah A Jefferson-Shah, Robert D Pesek, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 6, 2017
Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitisRobert D Pesek, Mallikarjuna Rettiganti, Erin O'Brien, et al.The Journal of Allergy and Clinical Immunology. Global|November 5, 2024
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infectionsKatherine Caid, Megan Tate, Shahwar Yousuf, et al.The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.The American Journal of Gastroenterology|April 23, 2019
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter ConsortiumRobert D Pesek, Craig C Reed, Amanda B Muir, et al.Digestive Diseases and Sciences|November 28, 2019
Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal DisordersRobert D Pesek, Craig C Reed, Margaret H Collins, et al.Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.The Journal of Allergy and Clinical Immunology|July 26, 2024
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitisLisa J Martin, Xue Zhang, Mirna Chehade, et al.Pageof 3